Fueling the Future: Funding for biotech, SaaS solutions, and a big AI investment from Kroger
October 8, 2020
St. Louis biotech startup C2N Diagnostics has secured roughly $2.2 million in funding from the Alzheimer’s Drug Discovery Foundation to advance “clinical validation and deployment” of its Alzheimer’s blood test, PrecivityAD.
Black-owned case management platform Courtroom5 has raised $20,000 in equity. The Durham-based “end-to-end legal toolbox” attracted five investors in this funding round.
Software-as-a-service startup Fulcrum, headquartered in Minneapolis, has raised $3.1 million in seed round funding. The company helps small to midsize manufacturers optimize their workflow and improve efficiency.
Pennsylvania clinical stage biopharmaceutical company Palladio Biosciences has completed a $20 million Series B investment, led by Samsara BioCapital. The company was founded in 2015 to develop drugs for orphan diseases of the kidney.
Kroger, based in downtown Cincy, has partnered with AI company Everseen. The idea is to reduce errors in the checkout process, especially self-checkout. Kroger plans to have the tech available in 2,500 stores across the US.
